ANKYLOSING SPONDYLITIS
Clinical trials for ANKYLOSING SPONDYLITIS explained in plain language.
Never miss a new study
Get alerted when new ANKYLOSING SPONDYLITIS trials appear
Sign up with your email to follow new studies for ANKYLOSING SPONDYLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for back pain: experimental drug LNK01001 enters final trial
Disease control Recruiting nowThis study tests a new medicine called LNK01001 for people with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 352 adults who haven't gotten enough relief from standard anti-inflammatory drugs will receive either LNK01001 or a placeb…
Matched conditions: ANKYLOSING SPONDYLITIS
Phase: PHASE3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
Poop pills could tame inflammation in arthritis and Crohn's
Disease control Recruiting nowThis study tests whether taking fecal transplants (processed stool from healthy donors) in capsule form can help control inflammation in people newly diagnosed with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's disease, or ulcerative colitis. Two hund…
Matched conditions: ANKYLOSING SPONDYLITIS
Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
New hope for back pain: drug 608 trial targets ankylosing spondylitis
Disease control Recruiting nowThis study tests a new drug called 608 in 500 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants will receive either 608 or a placebo to see if the drug improves symptoms like pain and mobility. The goal is to find a b…
Matched conditions: ANKYLOSING SPONDYLITIS
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
New hope for ankylosing spondylitis patients in korea
Disease control Recruiting nowThis study is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who have never used certain biologic drugs. It will test how well secukinumab works and how safe it is. About 70 participants will be observed over time to see if their symptoms and …
Matched conditions: ANKYLOSING SPONDYLITIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Needle therapy could ease stiff spine pain
Symptom relief Recruiting nowThis study tests a new, ultrasound-guided acupotomy technique to reduce disease activity in people with ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 60 adults with active disease will receive the treatment to see if it improves symptoms l…
Matched conditions: ANKYLOSING SPONDYLITIS
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Symptom relief
Last updated May 26, 2026 04:02 UTC
-
Gluten-Free diet may ease ankylosing spondylitis symptoms
Symptom relief Recruiting nowThis study looks at whether a gluten-free diet can reduce disease activity and improve quality of life in people with ankylosing spondylitis, a type of arthritis that affects the spine. Researchers will also check if the diet helps heal the gut. Sixty adults with stable treatment…
Matched conditions: ANKYLOSING SPONDYLITIS
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
New tool aims to help melanoma patients with autoimmune conditions navigate treatment choices
Knowledge-focused Recruiting nowThis study is testing a new educational tool designed for people with melanoma who also have an autoimmune disease (like rheumatoid arthritis or Crohn's disease). The tool helps patients understand immune checkpoint inhibitor drugs and their possible side effects. Researchers wil…
Matched conditions: ANKYLOSING SPONDYLITIS
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:59 UTC
-
Massive shoulder replacement study tracks 20,000 patients for over a decade
Knowledge-focused Recruiting nowThis study aims to understand how well shoulder replacements work over the long term by following up to 20,000 people for at least 10 years. Participants include those who have already had or are scheduled for shoulder replacement due to conditions like arthritis, rotator cuff te…
Matched conditions: ANKYLOSING SPONDYLITIS
Sponsor: Exactech • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC
-
Thousands join study to unlock secrets of arthritis and lupus
Knowledge-focused Recruiting nowThis study is building a large collection of health information and blood samples from 5,000 adults with rheumatic diseases like rheumatoid arthritis, lupus, and scleroderma. Researchers will use this data to find links between patient outcomes and biological markers. The goal is…
Matched conditions: ANKYLOSING SPONDYLITIS
Sponsor: Yale University • Aim: Knowledge-focused
Last updated May 26, 2026 03:53 UTC
-
Hunting the hidden triggers of autoimmune disease
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 300 people with autoimmune diseases like ulcerative colitis, multiple sclerosis, and Crohn's disease. Researchers will identify which T-cells are active in inflamed tissues and find their targets. The goal is to discover new targe…
Matched conditions: ANKYLOSING SPONDYLITIS
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
New study aims to decode back pain in ankylosing spondylitis patients
Knowledge-focused Recruiting nowThis study looks at different types of low back pain in 200 adults with ankylosing spondylitis. Researchers want to see how these pain types affect daily function and quality of life. Participants will fill out questionnaires during one visit. The goal is to better understand pai…
Matched conditions: ANKYLOSING SPONDYLITIS
Sponsor: Konya Beyhekim Training and Research Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC